trade

Drew Niv, Chief Executive Officer of FXCM Inc said, "FXCM delivered solid results in the second quarter. In particular, we are pleased with growing client equity to $839.0 million - up 97% from a year-ago and up 31% just from Dece

FXCM (NASDAQ:FXCM) reported Q2 EPS of $0.19, ahead of consensus estimates of $0.16 per share. Revenues for the quarter rose 9.2% year-over-year to $103.4 million, topping consensus estimates of $97.4 million.

There is no specific date set for his departure and McInenery will remain CFO through an appropriate transistion.

Mr. McInerney said, "I have been with the IAC family of companies for twelve years, and in my current position for the last six.

IAC (NASDAQ:IAC) announced that Thomas J. McInerney, EVP, and COO intends to leave the company at some point in the coming months, after 12 years with IAC.

Rosenberg began at Bank of America in 2002 after departing from Credit Suisse, where he was a director of U.S. investment-grade strategy.

Bank of America (NYSE:BAC) has a potential upside of 106.5% based on a current price of $6.77 and an average consensus analyst price target of $13.98.

Bloomberg reported that the head of global research of Bank of America (NYSE:BAC), Jeffrey Rosenberg left to join Blackrock Inc., according to a person familiar with the move, who declined to be identified because the announcement

The bank sees 2012 EPS of $3.31, vs. consensus estimates of $3.49 per share, and 2013 EPS of $3.35, vs. consensus estimates of $3.72 per share.

Best Buy has a potential upside of 52.2% based on a current price of $24.26 and an average consensus analyst price target of $36.93.

Citigroup lowered its price target for Best Buy Co. (NYSE:BBY) to $23 from $27 and maintained its sell rating on the stock.

In a statement, the four appointees are Greg Reichow for powertrain operations; Peter Carlsson, supply chain; Ravi Simhambhatla, information technology; and John Hillegass, design and retail development.

Last month, Toyota agreed to pay Tesla about $100 million to supply battery packs and motors for use in Toyota's electric RAV4 SUV that goes out on sale in 2012.

Tesla Motors Inc (NASDAQ:TSLA) has a potenti

Tesla Motors (NASDAQ:TSLA) hired four vice presidents as the car maker seeks to expand output, develop its Models S sedan model and aims to win a supply deal with Toyota (NYSE:TM).

The action brought strong disagreement, as regional Fed presidents Richard Fisher, Narayana Kocherlakota and Charles Plosser objected to the new terminology.

Federal Reserve Chairman Ben Bernanke led seven voters in favor of the decision, which came as the central bank said it expects a slower pace of recovery than what it anticipated during the last meeting in late June.

The Fed also indicate

On Tuesday the Federal Reserve put more clarity on what it means to hold interest rates low for an "extended period" of time, saying for the first time that it means "at least through mid-2013."

On the call side, General Dynamics (NYSE:GD) calls are trading over 15 times their average volume after the company secured a new contract with the U.S. Navy. OfficeMax (NYSE:OMX) calls are also very active today, trading over 13

The bank sees 2011 EPS of $4.10, up from $4.08 per share, and 2013 EPS of $5.08, down from $5.09 per share.

Target has a potential upside of 24.2% based on a current price of $47.73 and an average consensus analyst price target of $59.26.

Morgan Stanley adjusted its 2011, 2013 EPS estimates for Target Corp. (NYSE:TGT) and maintained its overweight rating and $64 price target.

The Princeton, N.J., company will give one added share to stockholders of record as of the close of business Aug. 22. The new shares will be circulated Aug. 31.

Pharmasset currently has around 37.7 million shares outstanding, and that will double to 75.4 million following the split.

The company, which currently has no products on the market, lost $22.6 million, or 60 cents per share, in the three months ended June 30.

Hepatitis C drug developer Pharmasset Inc.(NASDAQ:VRUS) reported Tuesday that its board of directors approved a two-for-one split of the company's common stock.

The bank sees a 2011 loss of $0.90 per share, wider than its previous estimate for a loss of $0.81 per share, and a 2012 loss of $0.36 per share, wider than its previous estimate for a loss of $0.34 per share.

MAKO Surgical has a potential upside of 22% based on a current price of $28.14 and an average consensus analyst price target of $34.33.

Morgan Stanley adjusted its 2011 and 2012 EPS estimates for MAKO Surgical Corp. (NASDAQ:MAKO) and maintained its equal-weight rating on the stock.